NIPH Clinical Trials Search

UMIN ID: UMIN000001294

Registered date:08/08/2008

Two institutional trial to evaluate the feasibility and efficacy of combined adjuvant therapy with gemcitabine and cisplatin for biliary tract cancer

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedBiriary tract cancer
Date of first enrollment2008/01/01
Target sample size30
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Administration of gemcitabine and cisplatin for adjuvant chemotherapy


Primary OutcomeFeasibility
Secondary OutcomeEfficacy

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteriaApparent infection Fever Heart disease Interstitial pneumonia, pulmonary fibrosis Other active cancers Brain metastasis Pericardial effusion Allergy of the drugs Pregnancy or patient's hope to be pregnant

Related Information


public contact
Name Osamu Kainuma
Address 666-2 Nitona, Chuo-ku, Chiba, Japan Japan
Telephone 043-264-5431
Affiliation Chiba Cancer Center Gastroenterological Surgery
scientific contact
Name Takehide Asano
Address 673 Nitona, Chuo-ku, Chiba, Japan Japan
Telephone 043-261-5171
Affiliation National Hospital Organization Chiba-East-Hospital Department of Surgery